The Accuracy of Sonotubometry to Assess the Eustachian Tube

Sponsor
James Tysome (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05740384
Collaborator
University of Cambridge (Other)
28
1
1
9
3.1

Study Details

Study Description

Brief Summary

The Eustachian tube (ET) connects the middle ear with the throat and is important for maintaining a healthy middle ear. Sonotubometry is a new method to measure how well the ET works by using sound. A speaker is placed at the nostril and a microphone records sound in the external ear canal. The ET is closed at rest and opens with swallowing. This is measured as an increase in sound measured in the external ear by sonotubometry.

Previous research has not proven that sonotubometry is reliable enough to be used in clinics to assess ET dysfunction (a disease where the ET does not open properly). In a recent study with healthy volunteers, it was possible to identify many of the existing issues of sonotubometry and improve the reliability of this method. This was primarily achieved by testing different sound types and sound volumes. This study aims to assess the reliability and usability of the new testing protocol in study participants with ET dysfunction. The results of this study will then be compared with the results from the previous study with healthy volunteers to work out how well sonotubometry works. Ultimately, this research aims to improve the ability to diagnose ET dysfunction.

Condition or Disease Intervention/Treatment Phase
  • Device: Sonotubometry Assessment
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
28 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
This is a validation study in 28 ears with Eustachian tube dysfunction.This is a validation study in 28 ears with Eustachian tube dysfunction.
Masking:
None (Open Label)
Masking Description:
The order of the assessment measurements is batch-wise randomised but there is no masking. Both the participant and investigator know what sort of measurements is being performed.
Primary Purpose:
Diagnostic
Official Title:
Assessing the Sensitivity and Specificity of Sonotubometry to Measure the Eustachian Tube Function
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Sep 30, 2023
Anticipated Study Completion Date :
Dec 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sonotubometry Assessment

All participants will be measured 8 times using sonotubometry. 2 times without applying any sound and 2 times while applying sound. This is done for both the left and right ear.

Device: Sonotubometry Assessment
The exact order of the measurements will be randomised: Recording type 1: No sound applied, 10 seconds recording of baseline noise, followed by recording when the participant is asked to swallow 3 times. Recording type 2: White noise applied, 10 seconds recording of baseline noise, followed by recording when the participant is asked to swallow 3 times. Ask for subjective feedback (did you hear a change in the sound in your ear on swallowing?) after each recording This is repeated using the contralateral ear and nostril. After successful recording, the microphone will be removed. For comparison, tubomanometry measurements will be performed on each ear. Tubomanometry is an alternative method to assess the middle ear and Eustachian tube. Afterwards, the participant's involvement in the study will be complete. The entire involvement will take about 50 minutes.

Outcome Measures

Primary Outcome Measures

  1. Assess Specificity and Sensitivity of Sonotubometry using a Custom-Built Sonotubometer [40-50 minutes]

    The main objective of the trial is to measure the specificity and sensitivity of an assessment method of the Eustachian tube called sonotubometry. To do this, eight sonotubometry measurements will be performed on each patient using the custom built Sonotubometry device. In total a maximum of 28 patients will be measured. This data will be compared to measurements from volunteers (data collected through a different study) to measure the sensitivity and specificity in percentage.

Secondary Outcome Measures

  1. Ability of Sonotubometry Measurements to detect Eustachian tube opening by using an Increased Sound Amplitude [40-50 minutes]

    The secondary objective is to assess if sonotubometry with an sound amplitude of 120dB is able to detect Eustachian tube opening. In the past a lower sound level was used (below 110dB) and thus the goal here is to measure the suitability of a higher sound pressure for sonotubometry. This will be measured by the ability of the new method to reliably detect the Eustachian tube function in patients and healthy volunteers (healthy volunteers data was gathered in a separate study)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participant is capable of giving informed consent (in the English language)

  • Participant has a current diagnosis of obstructive Eustachian tube dysfunction in the ear clinic at Addenbrooke's Hospital

  • Age 18 and over

Exclusion Criteria:
  • Cardiac pacemaker (incompatible with the large sonotubometry speaker magnet)

  • Discharging or infected ear (for infection control reasons)

  • Otitis Media with effusion (complicates test interpretation)

  • Cleft palate or Craniofacial abnormalities (complicates test interpretation)

  • Cholesteatoma (complicates test interpretation)

  • Nasopharyngeal mass (complicates test interpretation)

  • History of radiotherapy to the head and neck (can affect surrounding tissue structure)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cambridge University Hospitals NHS Foundation Trust Cambridge Cambridgeshire United Kingdom CB2 0QQ

Sponsors and Collaborators

  • James Tysome
  • University of Cambridge

Investigators

  • Principal Investigator: James Tysome, Dr, Cambridge University Hospitals NHS Foundation Trust

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
James Tysome, Principal Investigator, Cambridge University Hospitals NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT05740384
Other Study ID Numbers:
  • A096497
First Posted:
Feb 23, 2023
Last Update Posted:
Feb 23, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by James Tysome, Principal Investigator, Cambridge University Hospitals NHS Foundation Trust

Study Results

No Results Posted as of Feb 23, 2023